FDA Drug Application (206040) for LAMIVUDINE; ZIDOVUDINE; EFAVIRENZ by MYLAN LABS LTD

Back to FDA Applications sponsored by MYLAN LABS LTD

Application Number206040
Product Number001
FormTABLET;ORAL
Dosage150MG;300MG;600MG
Product Market Status Tentative Approval
Therapeutic Equivalence Evaluation Code
Reference Drug
Drug NameLAMIVUDINE; ZIDOVUDINE; EFAVIRENZ
Active IngredientLAMIVUDINE;ZIDOVUDINE;EFAVIRENZ



Back to FDA Applications sponsored by MYLAN LABS LTD

Problems, Comments, Suggestions? Click here to contact Greg Thatcher

Please read my Disclaimer





Copyright (c) 2013 Thatcher Development Software, LLC. All rights reserved. No claim to original U.S. Gov't works.